About Fabtech Technologies
Fabtech Technologies Ltd, incorporated in 2018, is a biopharma engineering company that specializes in turnkey projects and integrated engineering solutions. The company provides end-to-end services such as design, engineering, manufacturing, installation, and project management.
Fabtech is well-known for its expertise in cleanroom technology, HVAC systems, and process equipment, catering to global clients across life sciences, food & beverages, IT, semiconductors, and aeronautics industries. Its offerings include clean water solutions, clean air systems, modular facilities, and project execution with compliance to international standards.
As of July 31, 2025, the company had 185 permanent employees.
Why To Invest in Fabtech Technologies
Strong Financial Growth: Revenue grew by 46% and PAT increased by 71% in FY25 compared to FY24.
Healthy Margins: The company reported EBITDA margin of 14.07% and PAT margin of 13.83% in FY25.
Scalable Business Model: Fabtech serves diverse sectors like pharma, food, IT, and aerospace, reducing sector-specific risks.
Global Presence: Proven ability to execute projects across challenging geographies.
Robust Order Book: Diversified client base and strong track record in handling multiple dosage forms.
Experienced Leadership: Backed by the Fabtech Group with a seasoned management team.
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
---|---|---|---|
Assets | 426.56 | 269.24 | 213.86 |
Total Income | 335.94 | 230.39 | 199.91 |
Profit After Tax | 46.45 | 27.22 | 21.73 |
EBITDA | 47.28 | 40.69 | 34.86 |
NET Worth | 173.11 | 131.88 | 88.96 |
Reserves and Surplus | 140.72 | 128.94 | 86.18 |
Total Borrowing | 54.62 | 9.88 | 34.29 |
Explore Other Products